| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > 3 Simple Rules For Great Meetings |
|
Main Subject - 3 Simple Rules For Great Meetings
Meetings in our workplaces are getting worse each year. They are longer, have more participants, often involve remote employees and they rarely achieve as much value as the time investment would warrant. We know that meetings are often not viewed by participants as worthwhil According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e—at least not as worthwhile as whatever is on their wireless devices which they try to use clandestinely, but always unsuccessfully. What is it that can make meetings more productive? We believe that there are three simple rules that can turn ineffective meetings into event ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in that can yield business results. The three simple rules are: Determine the meeting goal upfront and communicate it to all participants. How often do participants find out about a meeting they have been asked to attend only a short time before the start of the meeting? One lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. member of a team may encounter a colleague in the corridor and tell him that he, too, was invited to the meeting which will start shortly. If the newly-informed invitee goes to the meeting, what are the chances that he will be prepared to contribute meaningfully to the agenda here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe Even if the right people are invited to the meeting ahead of time, most meeting conveners who even bother to send out an agenda, make the agenda pretty sparse—generally, the topics, the time allotted and the person assigned to report on each topic. This doesn’t give the par d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro icipants much of a hint on what it is about the topic that will be discussed, let alone what preparation they should do to contribute to the topic. The solution is to determine the goal of the meeting first. Why must you have a monthly team meeting? Is the goal to report on ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc departmental performance, company business results or to induce behavior change on the part of the participants? The meeting’s purpose may be to inform, to influence or to educate. In fact, a good meeting agenda will contain the goals for each topic, and it will be sent to easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ll participants in enough time that they can review it, prepare to add their perspectives on each topic or to provide additional information that the other participants may not have. Either way, a good agenda will answer the question: What do we need to accomplish in this me nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ting? Use structured brainstorming to get full participation. One of the most frustrating things about most meetings is the dialogue that occurs amongst participants. It is usually all over the map. If the topic is reducing expenses, there could be several great ideas offe and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ed, but, generally, there is a great deal of conversation, often rambling, with little to no closure on whether everyone agrees with the idea or is willing to try it out. Great ideas that go nowhere are sometimes called “plops.” Throw out an idea, hear some discussion around ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi it, and, “plop”—it goes nowhere. One good way to ensure that ideas are fully discussed or eliminated appropriately, is to use structured brainstorming. Most people are familiar with brainstorming where participants think through a topic and are then asked for their input. A ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ll ideas are taken with no judgment allowed and no discussion until all input is on the table. Structured brainstorming is an even better tool to ensure productive meeting dialogue. Here’s how it is done. The discussion leader asks participants to think silently about ways dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod o control departmental expenses, for example. Each person spends approximately 10-15 minutes silently brainstorming and writing one idea each on a post-it note. When each person runs out of ideas or the time is up, each person posts his or her post-it notes on a wall or flip cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin hart. The group reads all the post-it notes and groups similar ideas together. They then come up with a category header for each of the groupings. Out of the exercise, there should be several ideas which could be explored further and in more detail. Structured brainstormin tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen gives everyone an opportunity to participate fully in the discussion and provides a structure for looking at the ideas in categories. Thus, it provides the group with the ability to select those categories which could have the biggest impact on the problem they are trying to t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel solve. Never let a meeting end without an action plan. How many times have you been in meetings that have topics on the agenda that you thought had been covered in a previous meeting? Were these topics on this agenda because there was more to discuss or simply because no on ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e took ownership for actions on the topic in between the first and second meeting? Once a topic has been fully discussed, the meeting convener needs to ask the group what actions need to be taken to solve the issue or to make progress on the topic. Not every topic will need y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ollow on, but where they do, it is imperative to have someone accountable for taking action, reporting it to the group and doing so by some deadline. Having an agenda that leaves space for the action item, person responsible and due date, is a good way to ensure that each top . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de c that warrants follow up actions will get them. Then, you must determine if the action needs to be reported out prior to the next meeting or during it. Bringing closure to items on meeting agendas will add even more discipline and structure to meetings. These three suggest elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ons for conducting meetings may not prevent the wireless addicts from working their phones or other devices during the meeting, but they certainly will provide an opportunity for all meeting participants to contribute as fully as they desire to help you achieve better meetings tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Audit Recruitment - A Crash Course in Auditing The Very Best Time to Get a Job on a Cruise Ship!
|